48
Views
3
CrossRef citations to date
0
Altmetric
Miscellaneous

Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaques

, , &
Pages 693-704 | Published online: 24 Feb 2005

Bibliography

  • LIBBY P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation (2001) 104:365–372.
  • ••Detailed review of plaque morphology andmechanisms of plaque disruption.
  • VIRMANI R, BURKE AP & FARB A: Plaque rupture and plaque erosion. Thromb. Haemost. (1999) 82 (Suppl. 1):1–3.
  • LIBBY P: Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin. Cardiol (2000) 23 (Suppl. 6):VI–3–7.
  • YAMAGISHI M, TERASHIMA M, AWANO K et al.: Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. I Am. Coll. Cardiol (2000) 35:106–111.
  • SCHOENHAGEN P, ZIADA KM, VINCE DG, NISSEN SE, TUZCU EM: Arterial remodeling and coronary artery disease: the concept of 'dilated' versus 'obstructive' coronary atherosclerosis. Am. Coll. Cardiol (2001) 38:297–306.
  • •The size of the vessel lumen may be preserved despite significant plaque burden. Detailed review of this concept.
  • RAGGI P: Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. Am. J. Cardiol (2001) 87:27A–34A.
  • KEELAN PC, BIELAK LF, ASHAI K et al.: Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation (2001) 104:412–417.
  • WAYHS R, ZELINGER A, RAGGI P: High coronary artery calcium scores pose an extremely elevated risk for hard events. J. Am. Coll. Cardiol (2002) 39:225–230.
  • ••Patients with high coronary calcium scores,followed prospectively, had an increased incidence of cardiovascular events.
  • HUANG H, VIRMANI R, YOUNIS H, BURKE AP, KAMM RD, LEE RT: The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation (2001) 103:1051–1056.
  • •Calcified plaques were more mechanically stable and less prone to disruption than non-calcified plaques.
  • SIMONS PC, ALGRA A, BOTS ML, GROBBEE DE, VAN DER GRAAF Y: Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 100:951–957.
  • LEKAKIS JP, PAPAMICHAEL CM, CIMPONERIU AT et al.: Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Jim. Cardiol (2000) 85:949–952.
  • MACK WJ, LABREE L, LIU C, SELZER RH, HODIS HN: Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis (2000) 150:371–379.
  • NAGHAVI M, MADJID M, KHAN MR, MOHAMMADI RM, WILLERSON JT, CASSCELLS SW: New developments in the detection of vulnerable plaque. Carr Atheroscler. Rep. (2001) 3:125–135.
  • FATHI R, MARWICK TH: Noninvasive tests of vascular function and structure: why and how to perform them. Jim. Heart .1. (2001) 141:694–703.
  • DE GROOT E, JUKEMA JW, MONTAUBAN VAN SWIJNDREGT AD et al: B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). I Am. Coll. Cardiol (1998) 31:1561–1567.
  • BALDASSARRE D, VEGLIA F, GOBBI C et al: Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study. Atherosclerosis (2000) 151:575–583.
  • CORTI R, FAYAD ZA, FUSTER V et al.: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 104:249–252.
  • •Plaque regression on statin therapy detected non-invasively with MRI.
  • WICKLINE SA, SHEPARD RK, DAUGHERTY A: Quantitative ultrasonic characterization of lesion composition and remodeling in atherosclerotic rabbit aorta. Arterioscler. Thromb. (1993) 13:1543–1550.
  • URBANI MP, PICANO E, PARENTI G et al.: In vivo radiofrequency-based ultrasonic tissue characterization of the atherosclerotic plaque. Stroke (1993) 24:1507–1512.
  • GRONHOLDT ML, NORDESTGAARD BG, WIEBE BM, WILHJELM JE, SILLESEN H: Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation (1998) 97:34–40.
  • IANNUZZI A, WILCOSKY T, MERCURI M, RUBBA P, BRYAN FA, BOND MG: Ultrasonographic correlates of carotid atherosclerosis in transient ischemic attack and stroke. Stroke (1995) 26:614–619.
  • GRONHOLDT ML, NORDESTGAARD BG, SCHROEDER TV, VORSTRUP S, SILLESEN H: Ultrasonic echolucent carotid plaques predict future strokes. Circulation (2001) 104:68–73.
  • EL-BARGHOUTY NM, LEVINE T, LADVA S, FLANAGAN A, NICOLAIDES A: Histological verification of computerised carotid plaque characterisation. Eur. Vasc. Endovasc. Stag. (1996) 11:414–416.
  • TAKIUCHI S, RAKUGI H, HONDA K et al.: Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation (2000) 102:766–770.
  • ••Integrated backscatter analysis correlatedwell with histology in the assessment of carotid plaque composition.
  • CESPEDES El, DE KORTE CL, VAN DER STEEN AF, VON BIRGELEN C, LANCEE CT: Intravascular elastography: principles and potentials. &min. Interventional Cardiol (1997) 2:55–62.
  • DE KORTE CL, PASTERKAMP G, VAN DER STEEN AF, WOUTMAN HA, BOM N: Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries M vitro. Circulation (2000) 102:617–623.
  • ••Elastography was able to distinguish lipid-rich areas of plaque from less deformable fibrous portions.
  • TENENBAUM A, GARNIEK A, SHEMESH J et al.: Dual-helical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocardiography. Radiology (1998) 208:153–158.
  • ESTES JM, QUIST WC, LO GERFO FW,COSTELLO P: Noninvasive characterization of plaque morphology using helical computed tomography. Cardiovasc. Surg. (1998) 39:527–534.
  • SCHROEDER S, KOPP AF, BAUMBACH A et al.: Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J. Am. Coll. Cardiol (2001) 37:1430–1435.
  • ••Coronary plaque characterisation byMDCT compared favourably with assessment by intracoronary ultrasound.
  • ACHENBACH S, GIESLER T, ROPERS D et al.: Detection of coronary artery stenoses by contrast-enhanced, retrospectively electrocardiographically-gated, multislice spiral computed tomography. Circulation (2001) 103:2535–2538.
  • SCHROEDER S, KOPP AF, BAUMBACH A et al.: Noninvasive detection of coronary lesions by multislice computed tomography: results of the New Age pilot trial. Cathet. Cardiovasc. Interventions (2001) 53:352–358.
  • KIM WY, DANIAS PG, STUBER M et at: Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl. J. Med. (2001) 345:1863–1869.
  • ••Large multi-centre trial comparing MRIcoronary angiography with invasive coronary angiography.
  • FAYAD ZA, FUSTER V: Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann. NY Acad. Sci. (2000) 902:173–186.
  • SERFATY JM, CHAABANE L, TABIB A, CHEVALLIERJM, BRIGUET A, DOUEK PC: Atherosclerotic plaques: classification and characterization with T2-weighted high-spatial-resolution MR imaging- an M vitro study. Radiology (2001) 219:403–410.
  • TOUSSAINT JF, SOUTHERN JF, FUSTER V, KANTOR HL: T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. (1995) 15:1533–1542.
  • ••Early study demonstrating the ability of T2-weighted MRI to distinguish various plaque components.
  • HALLIBURTON SS, PASCHAL CB: Atherosclerotic plaque components in human aortas contrasted by ex vivoimaging using fast spin-echo magnetic resonance imaging and spiral computed tomography. [erratum appears in Invest. Radial. 1997 Jan;32(1):65]. Invest. Radial. (1996) 31:724–728.
  • HATSUKAMI TS, ROSS R, POLISSAR NL, YUAN C: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 102:959–964.
  • ••Use of bright-blood MRI to visualise thefibrous cap of atherosclerotic carotid plaques.
  • YUAN C, KERWIN WS, FERGUSON MS et al.: Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. Magn. Reson. Imaging (2002) 15:62–67.
  • FAYAD ZA, FALLON JT, SHINNAR Met al.: Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice (see comments). Circulation (1998) 98:1541–1547.
  • HELFT G, WORTHLEY SG, FUSTER Vet al.: Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J. Ana. Coll. Cardiol (2001) 37:1149–1154.
  • MCCONNELL MV, AIKAWA M, MATER SE, GANZ P, LIBBY P, LEE RT: MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler. Thromb. Vasc. Biol. (1999) 19:1956–1959.
  • •MRI was able to detect the impact of a low cholesterol diet on atherosclerotic plaques in the rabbit aorta.
  • WORTHLEY SG, HELFT G, FUSTER V et al.: High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis (2000) 150:321–329.
  • WORTHLEY SG, HELFT G, FUSTER V et al.: Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation (2000) 101:2956–2961.
  • YUAN C, MITSUMORI LM, FERGUSON MS et al.: hi vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation (2001) 104:2051–2056.
  • ••MRI assessment of carotid plaquecomposition prior to endarterectomy correlated well with histology.
  • TOUSSAINT JF, LAMURAGLIA GM, SOUTHERN JF, FUSTER V, KANTOR HL: Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation (1996) 94:932–938.
  • •Early study demonstrating the ability of MRI to characterise the composition of atherosclerotic plaques in vivo.
  • VON INGERSLEBEN G, SCHMIEDL UP, HATSUKAMI TS et al.: Characterization of atherosclerotic plaques at the carotid bifurcation: correlation of high-resolution MR imaging with histologic analysis-preliminary study. Radiographics (1997) 17:1417–1423.
  • FAYAD ZA, NAHAR T, FALLON JT et al.:In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 101:2503–2509.
  • YUAN C, HATSUKAMI TS, OBRIEN KD: High-Resolution magnetic resonance imaging of normal and atherosclerotic human coronary arteries ex vivo: discrimination of plaque tissue components. Investig. Med. (2001) 49:491–499.
  • FAYAD ZA, FUSTER V, FALLON JT et al: Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 102:506–510.
  • ••Study demonstrating the feasibility andchallenges of in vivo MRI coronary wall imaging.
  • BOTNAR RM, STUBER M, KISSINGER KV, KIM WY, SPUENTRUP E, MANNING WJ: Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation (2000) 102:2582–2587.
  • ••Study demonstrating the feasibility andchallenges of in vivo MRI coronary wall imaging.
  • WEISSLEDER R, MAHMOOD U: Molecular imaging. Radiology (2001) 219:316–333.
  • ••Excellent review of the general principles and potential applications of molecular imaging.
  • RUDD J, WARBURTON E, FRYER T et al.: Atherosclerotic Plaque Inflammation Imaged with 18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET). Circulation (2001) 104:693.
  • ••Initial results of this study show that FDG-PET can identify inflamed plaques, and those plaques associated with clinical events.
  • RUEHM SG, COROT C, VOGT P, KOLB S, DEBATIN JF: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation (2001) 103:415–422.
  • ••Iron oxide particles accumulate in plaquemacrophages and can be used to detect inflamed plaques with MRI.
  • VILLANUEVA FS, JANKOWSKI RJ, KLIBANOV S et al.: Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation (1998) 98:1–5.
  • LINDNER JR: Assessment of inflammationwith contrast ultrasound. Frog. Cardiovasc. Dis. (2001) 44:111–120.
  • •Ability of contrast microbubbles to detect areas of high inflammatory activity discussed.
  • TSIMIKAS S, SHORTAL PP, WITZTUM JL, PALINSKI W: In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Arterioscler. Thromb. Vasc. Biol. (2000) 20:689–697.
  • TSIMIKAS S, PALINSKIW, HALPERN SE, YEUNG DW, CURTISS LK, WITZTUM JL: Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo (see comments). J. Nuclear Cardiol (1999) 6:41–53.
  • VALLABHAJOSULA S, FUSTER V: Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J. Nuclear Med. (1997) 38:1788–1796.
  • LANZA GM, WALLACE KD, FISCHER SE et al.: High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med. Biol. (1997) 23:863–870.
  • •Targeted ultrasonic microbubbles were able to selectively detect thrombus.
  • FLACKE S, FISCHER S, SCOTT MJ et al: Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation (2001) 104:1280–1285.
  • •Successful use of a fibrin-targeted MRI contrast agent to detect plaque-associated thrombus.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.